Company Description
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America.
It operates through two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.
The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, and other skin conditions; and TheraClear acne therapy system for the treatment of mild to moderate inflammatory, comedonal, and pustular acne.
It serves dermatologists and dermatological group clinics. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016.
STRATA Skin Sciences, Inc. was incorporated in 1989 and is headquartered in Horsham, Pennsylvania.
| Country | United States |
| Founded | 1989 |
| IPO Date | Oct 28, 2005 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 106 |
| CEO | Dolev Rafaeli |
Contact Details
Address: 5 Walnut Grove Drive, Suite 140 Horsham, Pennsylvania 19044 United States | |
| Phone | 215 619 3200 |
| Website | strataskinsciences.com |
Stock Details
| Ticker Symbol | SSKN |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001051514 |
| CUSIP Number | 86272A206 |
| ISIN Number | US86272A3059 |
| Employer ID | 13-3986004 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Dolev Rafaeli Ph.D. | President, Chief Executive Officer and Vice-Chairman |
| John Gillings | Principal Financial Officer and Chief Accounting Officer |
| Shmuel Gov | Chief Operating Officer |
| Jay Sturm | General Counsel and Corporate Secretary |
| Michael R. Stewart | Independent Consultant |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2025 | 10-Q | Quarterly Report |
| Nov 13, 2025 | 8-K | Current Report |
| Nov 7, 2025 | SCHEDULE 13G/A | Filing |
| Oct 30, 2025 | DEF 14A | Other definitive proxy statements |
| Oct 20, 2025 | PRE 14A | Other preliminary proxy statements |
| Oct 16, 2025 | 8-K | Current Report |
| Oct 15, 2025 | 424B5 | Filing |
| Oct 14, 2025 | 8-K | Current Report |
| Sep 26, 2025 | 424B5 | Filing |
| Sep 8, 2025 | SCHEDULE 13G | Filing |